Research output per year
Research output per year
Fingerprint
Dive into the research topics where Mingjiang Xu is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 6 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
HOXBLINC long non-coding RNA activation promotes leukemogenesis in NPM1-mutant acute myeloid leukemia
Zhu, G., Luo, H., Feng, Y., Guryanova, O. A., Xu, J., Chen, S., Lai, Q., Sharma, A., Xu, B., Zhao, Z., Feng, R., Ni, H., Claxton, D., Guo, Y., Mesa, R. A., Qiu, Y., Yang, F. C., Li, W., Nimer, S. D., Huang, S. & 1 others, , Dec 2021, In: Nature communications. 12, 1, 1956.Research output: Contribution to journal › Article › peer-review
Open Access -
Characteristics of myeloid sarcoma in mice and patients with TET2 deficiency
Wang, J., Miao, Z., Jiang, Y., Zou, P., Li, W., Tang, X., Lv, Y., Xing, D., Chen, S., Yang, F., Xu, M., Cao, Z., Wang, H. & Zhao, Z., Jun 1 2020, In: Oncology Letters. 19, 6, p. 3789-3798 10 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Context dependent effects of ascorbic acid treatment in TET2 mutant myeloid neoplasia
Guan, Y., Greenberg, E. F., Hasipek, M., Chen, S., Liu, X., Kerr, C. M., Gackowski, D., Zarakowska, E., Radivoyevitch, T., Gu, X., Willard, B., Visconte, V., Makishima, H., Nazha, A., Mukherji, M., Sekeres, M. A., Saunthararajah, Y., Oliński, R., Xu, M., Maciejewski, J. P. & 1 others, , Dec 1 2020, In: Communications Biology. 3, 1, 493.Research output: Contribution to journal › Article › peer-review
Open Access8 Scopus citations -
Erratum: Characteristics of myeloid sarcoma in mice and patients with TET2 deficiency (Oncology Letters (2020) 19 (3789-3798) DOI: 10.3892/ol.2020.11479)
Wang, J., Miao, Z., Jiang, Y., Zou, P., Li, W., Tang, X., Lv, Y., Xing, D., Chen, S., Yang, F., Xu, M., Cao, Z., Wang, H. & Zhao, Z., Oct 2020, In: Oncology Letters. 20, 4, e11907.Research output: Contribution to journal › Comment/debate › peer-review
Open Access -
Proteolysis targeting chimeras (PROTACs) are emerging therapeutics for hematologic malignancies
He, Y., Khan, S., Huo, Z., Lv, D., Zhang, X., Liu, X., Yuan, Y., Hromas, R., Xu, M., Zheng, G. & Zhou, D., Jul 27 2020, In: Journal of Hematology and Oncology. 13, 1, 103.Research output: Contribution to journal › Review article › peer-review
Open Access6 Scopus citations
Press / Media
-
UT Health San Antonio: Dr. Mingjiang Xu receives UT System award to support cancer epigenetics research
10/9/20
1 item of Media coverage
Press/Media: Press / Media
-
S.A.’s Mays Cancer Center gets $10.3M in state funding
Luiz O Penalva, Dmitri N Ivanov, Mingjiang Xu & Ruben Mesa
8/28/20
2 items of Media coverage
Press/Media: Press / Media
-
University of Texas Health Science Center at San Antonio: CPRIT Awards Mays Cancer Center More Than $10.3 Million
Raushan T Kurmasheva, Luiz O Penalva, Dmitri N Ivanov, Manjeet K Rao, Mingjiang Xu & Ruben Mesa
8/21/20
1 item of Media coverage
Press/Media: Press / Media
-
These SA institutions to get over $10M in cancer research funding
8/19/20
2 items of Media coverage
Press/Media: Press / Media
-
LEUKEMIA AND LYMPHOMA SOCIETY AWARDS PRESTIGIOUS GRANT TO SYLVESTER TO ACCELERATE EPIGENETIC RESEARCH
11/20/17
1 item of Media coverage
Press/Media: Press / Media